For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Six takeaways from the recent Obamacare announcements
Every year, health insurers participating in the Exchanges (Obamacare) must announce their planned premium increases for the following year well in advance, so federal…
Blog
The free market case for AI chatbots in mental health care
Concerns that new technologies may cause negative psychosocial effects are part of a growing public conversation. Questions regarding the intersection between the digital world…
Blog
The fraud problem hidden in the subsidy debate
Last fall, critics argued that under the Republican budget plan, 22.4 million people would see their Obamacare subsidies reduced to prepandemic levels. As Jeremy…
Search Posts
Blog
The TrumpRx medicine will prove worse than the disease
On September 30, President Trump, standing alongside the CEO of Pfizer, announced a multifaceted deal wherein Pfizer would inoculate itself from new regulations…
Blog
Free the Economy podcast: Obamacare problems with Jeremy Nighohossian
In this week’s episode we talk about the unintended consequences of the Sarbanes-Oxley Act of 2002, decarbonization of economic growth, and…
Blog
The problem with Obamacare is Obamacare
This year, the COVID-induced expansion of the Affordable Care Act (ACA) will expire. Extending the expanded subsidies has become a point of contention between…
News Release
Report: Pharmaceutical tariffs will upend prices, supply
A new CEI report takes a close look at the complex, worldwide pharmaceutical supply chain to anticipate how forthcoming Trump tariffs might increase prices…
Study
I, Pharmaceutical
The global pharmaceutical industry is complex. This is true not only in the number of countries involved but the range of products, the sets…
News Release
Trump’s views on Tylenol shouldn’t supersede doctor advice
President Trump railed against Tylenol (acetaminophen) in a press conference this week, imploring, in particular, pregnant women and babies to not take (or be…